Vcanbio Cell & Gene Engineering Co., Ltd. (600645)
Market Open
16 Oct, 06:57 AM
SSE SSE Primary ¥
17. 39
+0.02
+0.1151%
¥
9.7B Market Cap
- P/E Ratio
0.02% Div Yield
8.95M Volume
- Eps
¥ 17.37
Previous Close Want to track 600645 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | 0.06 |
| | | - | - |
| | | - | - |
| | | - | 0.33 |
| | | - | 0.42 |
| | | - | 0.09 |
600645 Earnings Reports FAQ
What is the earnings per share (EPS) for 600645?
EPS data for 600645 is currently not available, as Vcanbio Cell & Gene Engineering Co., Ltd has not reported recent earnings.
What is the company's earnings growth rate?
Over the past 10 years, the earnings growth rate has been approximately -36.22%, reflecting the 600645's performance and SSE market conditions.
When is the next earnings release date?
Vcanbio Cell & Gene Engineering Co., Ltd has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Vcanbio Cell & Gene Engineering Co., Ltd are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 600645 at this time, as Vcanbio Cell & Gene Engineering Co., Ltd has no recent EPS data to calculate it.
2026 © Marketlog. All Rights Reserved.
